Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. Bachem Holding AG
  6. Company
    BANB   CH0012530207

BACHEM HOLDING AG

(BANB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Bachem Holding AG
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.

Number of employees : 1 529 people.
Sales per Business
20192020Delta
CHF (in Million)%CHF (in Million)%
Active Pharmaceutical Ingredients276.6188.2%360.3589.6% +30.27%
Research Chemicals37.1011.8%41.6410.4% +12.24%
Sales per region
20192020Delta
CHF (in Million)%CHF (in Million)%
North America155.1549.5%217.0254% +39.88%
Europe / Asia158.5650.5%184.9846% +16.66%
Managers
NameAgeSinceTitle
Thomas Meier522020Chief Executive Officer
Alain Schaffter-2021Chief Financial Officer
Günther Loidl502015Chief Technology Officer
Ralph Schönleber-2003Vice President-Research & Development
Roland Schürmann562020Chief Operating Officer
Thomas Früh, Dr.632020Secretary & Director
Anne-Kathrin Stoller, Dr.462018Chief Marketing Officer
Boris Corpataux-2019Vice President-BD & Sales Europe
Manuela Schneider-Höfferer, Dr.-2020Vice President-Global Marketing
Christoph Schuhr, Dr.-2018VP-Quality Assurance & Regulatory Affairs
Members of the board
NameAgeSinceTitle
Kuno Sommer642012Chairman
Peter Grogg78-Honorary Chairman
Jürgen Brokatzky-Geiger, Dr.682009Non-Executive Director
Nicole Grogg Hötzer47-Vice Chairman
Helma Wennemers, Dr.512014Non-Executive Director
Steffen Lang, Dr.532020Director
Thomas Früh, Dr.632020Secretary & Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 6,997,941 6,005,202 85.8% 3,638 0.1% 42.9%
Stock B 1 7,002,059 0 0.0% 0 0.0%
Shareholders
NameEquities%
Grogg Family 829,718 11.9%
Peter Grogg 795,941 11.4%
Capital Research & Management Co. (World Investors) 392,875 5.61%
VV Vermögensverwaltung AG 237,500 3.39%
Norges Bank Investment Management 176,769 2.53%
The Vanguard Group, Inc. 146,037 2.09%
Zürcher Kantonalbank (Investment Management) 141,098 2.02%
Vontobel Asset Management AG 122,570 1.75%
Standard Life Investments Ltd. 119,250 1.70%
UBS Asset Management Switzerland AG 113,515 1.62%
Holdings
NameEquities%Valuation
Bachem Holding AG (BANB) 3,6380.052%1,996,278 USD
Company contact information
Bachem Holding AG
Hauptstrasse 144
Bubendorf, Basel-Landschaft (Basle Country) 4416

Phone : +41.58.595.20.21
Fax : +41.58.595.20.43
Web : http://www.bachem.com
Sector Other Biotechnology & Medical Research
1st jan.Capitalization (M$)
BACHEM HOLDING AG30.47%8 032
MODERNA, INC.89.37%79 438
LONZA GROUP AG17.02%54 990
IQVIA HOLDINGS INC.36.31%46 809
CELLTRION, INC.-25.07%33 149
SEAGEN INC.-13.60%27 461
HANGZHOU TIGERMED CONSULTING CO., LTD14.64%23 290
PHARMARON BEIJING CO., LTD.56.66%22 324
CUREVAC N.V.16.92%21 497
ALNYLAM PHARMACEUTICALS, INC.29.49%19 783
INCYTE CORPORATION-4.85%18 280
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.41.82%17 735
BIO-TECHNE CORPORATION39.36%17 211
PPD, INC.35.45%16 278
NOVAVAX, INC.58.05%13 054
ICON PUBLIC LIMITED COMPANY7.99%11 130
QIAGEN N.V.-9.12%10 970
PRA HEALTH SCIENCES, INC.32.68%10 785
CRISPR THERAPEUTICS AG-19.07%9 928
SYNEOS HEALTH, INC.24.48%8 763
GENSCRIPT BIOTECH CORPORATION176.60%8 473
Connections : Bachem Holding AG